The skin is the largest organ of the body, which meets the environment most directly. Thus, the skin is vulnerable to various damages, particularly burn injury. Skin replacement therapies are second-line treatment options for the patients suffering from diabetic ulcer complications.
Skin disorder is a major concern impacting large group of people across the globe. There is increase in percentage of inpatients in hospitals related to burn cases. According to National Center for Health Statistics, up to 10,000 people in the United States die every year of burn-related infections. Each year in the United States, 1.1 million burn injuries require medical attention. With the increase in percentage of skin disorder patients demand for advanced skin treatment is gaining traction. Rapid technological advancements taking place in skin grafting and high investment for R&D activities are major factors expected to drive the growth of global skin replacement therapy market. Noticeable increase in chronic wounds and increase in awareness among patients related to advanced skin therapy are factors expected to support the growth of target market. Government of developed and developing countries are spending high on the development of healthcare infrastructure in order to support the R&D activities along with advancements in biosynthetic and synthetic skin grafts from major players are factors expected to impact the growth of skin replacement therapy market. Major players approach towards enhancing the business through strategic acquisition and innovative product launches u order to attract new customers are factors expected to augment the growth of skin replacement therapy market.
In 2019, AVITA Medical Limited, a global medical solution and service provider launched autologous cell harvesting device “RECELL System”. The product was launched in the US market for the treatment of acute thermal burns in patients aged 18 years and older. This helped the company to enhance the business and increase the customer base.
In 2019, Procter & Gamble, a multinational consumer goods company launched “Opté”. The product is used for the treatment of patients covering skin conditions such as hyperpigmentation, and age spots by simply gliding the device over the skin’s surface. The product launch helped the company to enhance the product offerings and increase the revenue share.
Rise in incidence of accidents such as road accidents and trauma events and presence of non-profit organization focused to provide better treatment to patients are factors expected to support the growth of skin replacement therapy market. Factors such as availability of alternative therapies and high cost associated to surgeries are expected to hamper the growth of global skin replacement therapy market. In addition, lack of awareness and stringent government regulations are factors expected to challenge the growth of target market. However, increasing clinical trials by major players, high investment for R&D activities and approach towards bio-engineered skin replacement are factors expected to create new opportunities for players operating in the skin replacement therapy market over the forecast period. In addition, increasing partnership and agreements between regional and international players is expected to support the revenue transaction of the target market.
Segment Analysis by Region
The market in North America is expected to account for major revenue share in the global skin replacement therapy market due to high patient pool suffering from skin disorder. In addition, presence of large number of players operating in the country and introduction of innovative solutions are factors expected to support the growth of target market. Increasing acquisition activities by players in order to enhance the business is expected to support the skin replacement therapy market growth.
The global skin replacement therapy market is highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Skin Replacement Therapy Market Segment Analysis, 2019
The global skin replacement therapy market is segmented into material used and end user. The material used segment is divided into spider silk and collagen. Among material used segment the collagen segment is expected to account for significant revenue share in the global skin replacement therapy market. The end user segment is divided into hospitals and clinics, academic and research, others. The players profiled in the report are Cellular Dynamics International, Tengion, Cynata Therapeutics Limited, Platelet BioGenesis, and TissueGene, Inc.
Market By Material Used
Market By End User
Hospitals and Clinics
Academic and Research
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Rapid technological advancements taking place in skin grafting and high investment for R&D activities are major factors expected to drive the growth of global skin replacement therapy market.
In material used the spider silk segment is growing at faster pace.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are Cellular Dynamics International, Tengion, and Cynata Therapeutics Limited.
The Europe is expected to account for major revenue share in the global market.
In end user the hospitals and clinics segment is growing at faster pace.
Factors such as availability of alternative therapies and high cost associated to surgeries are expected to hamper the growth of global skin replacement therapy market.